Utility of SOFA score, management and outcomes of sepsis in Southeast Asia: a multinational multicenter prospective observational study

Journal of Intensive Care
Khie Chen Liefor Southeast Asia Infectious Disease Clinical Research Network

Abstract

Sepsis is a global threat but insufficiently studied in Southeast Asia. The objective was to evaluate management, outcomes, adherence to sepsis bundles, and mortality prediction of maximum Sequential Organ Failure Assessment (SOFA) scores in patients with community-acquired sepsis in Southeast Asia. We prospectively recruited hospitalized adults within 24 h of admission with community-acquired infection at nine public hospitals in Indonesia (n = 3), Thailand (n = 3), and Vietnam (n = 3). In patients with organ dysfunction (total SOFA score ≥ 2), we analyzed sepsis management and outcomes and evaluated mortality prediction of the SOFA scores. Organ failure was defined as the maximum SOFA score ≥ 3 for an individual organ system. From December 2013 to December 2015, 454 adult patients presenting with community-acquired sepsis due to diverse etiologies were enrolled. Compliance with sepsis bundles within 24 h of admission was low: broad-spectrum antibiotics in 76% (344/454), ≥ 1500 mL fluid in 50% of patients with hypotension or lactate ≥ 4 mmol/L (115/231), and adrenergic agents in 71% of patients with hypotension (135/191). Three hundred and fifty-five patients (78%) were managed outside of ICUs. Ninety-nine patients (22%) died....Continue Reading

References

Jan 21, 2006·Critical Care Medicine·Jean-Louis VincentUNKNOWN Sepsis Occurrence in Acutely Ill Patients Investigators
Jul 31, 2008·Critical Care Medicine·Allen C ChengSharon J Peacock
Dec 19, 2008·Critical Care : the Official Journal of the Critical Care Forum·Lilian MinneEvert de Jonge
May 13, 2010·Critical Care : the Official Journal of the Critical Care Forum·Teresa CardosoAltamiro Costa-Pereira
May 28, 2011·The New England Journal of Medicine·Kathryn MaitlandUNKNOWN FEAST Trial Group
Jul 1, 2007·Asian Journal of Transfusion Science·Jayashree Sharma, Moushumi Suryavanshi
Feb 22, 2012·Intensive Care Medicine·Martin W DünserUNKNOWN Global Intensive Care Working Group of European Society of Intensive Care Medicine
Oct 30, 2012·The Lancet Infectious Diseases·Mitchell M LevyR Phillip Dellinger
Jan 29, 2013·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup
Oct 3, 2014·Critical Care Medicine·Mitchell M LevyR Phillip Dellinger
Sep 18, 2015·PLoS Neglected Tropical Diseases·Federico CostaAlbert I Ko
Sep 29, 2015·American Journal of Respiratory and Critical Care Medicine·Carolin FleischmannUNKNOWN International Forum of Acute Care Trialists
Feb 3, 2016·Chest·Samuel M BrownUNKNOWN NIH/NHLBI PETAL Network Collaborators
Feb 24, 2016·Critical Care Medicine·Christopher W SeymourDerek C Angus
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Christopher W SeymourDerek C Angus
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Mervyn SingerDerek C Angus
May 28, 2016·Clinics in Chest Medicine·Matthew W Semler, Todd W Rice
Oct 16, 2016·Intensive Care Medicine·C Louise ThwaitesUNKNOWN sepsis in resource-limited settings–expert consensus recommendations group* of the European Society of Intensive Care Medici
Nov 13, 2016·Journal of Critical Care·Alfred PapaliUNKNOWN Haiti REsource Limited Intensive Care (Haiti-RELIC) Study Group
Dec 10, 2016·SpringerPlus·Seung Chun PaekThomas T H Wan
Jan 20, 2017·Intensive Care Medicine·Andrew RhodesR Phillip Dellinger
Jan 21, 2017·The Lancet Global Health·UNKNOWN Southeast Asia Infectious Disease Clinical Research Network
Apr 25, 2017·PloS One·Prapit TeparrukkulDirek Limmathurotsakul

❮ Previous
Next ❯

Citations

Jul 20, 2019·Turkish Journal of Emergency Medicine·Rodrigo de Freitas GarberoVinícius Gabriel Monteiro von Zuben
Feb 9, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shelton W WrightT Eoin West
Sep 16, 2020·Expert Review of Anti-infective Therapy·Fahad A S AleidanAbdel Galil Abdel Gadir
Nov 30, 2019·Critical Care : the Official Journal of the Critical Care Forum·Simon LambdenBruno Francois

❮ Previous
Next ❯

Software Mentioned

STATA
OpenClinica

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved